Hyperbaric oxygen before surgery for hormone-positive breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether giving hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard treatment can help shrink hormone receptor-positive breast cancer tumors. It aims to see if this added treatment is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 60.
- You have been diagnosed with hormone receptor-positive breast cancer (a type that grows in response to hormones).
- Your cancer is at a stage where neoadjuvant therapy (treatment before surgery) is recommended.
- You have not had hyperbaric oxygen therapy before.
- You do not have certain lung, ear, or eye conditions that make hyperbaric oxygen unsafe.
- You are generally healthy enough for treatment (good heart, liver, kidney, and blood function).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy for breast cancer. The goal is to see if it helps shrink the tumor more effectively before surgery.
This study tests whether giving hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy can help shrink breast tumors more effectively. It is for women with triple-negative or HER2-positive breast cancer who are scheduled for neoadjuvant therapy.
This trial tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen) can prevent lung inflammation caused by breast cancer radiation. It may help reduce the risk of radiation pneumonitis in certain breast cancer survivors.
This trial tests a combination of targeted drugs and chemotherapy before surgery for HER2-positive breast cancer. It aims to see if this approach can shrink or eliminate the tumor, making surgery more effective.
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can slow the growth of breast cancer that has spread to the lungs. You would receive this treatment alongside standard care if your cancer has grown despite prior chemotherapy.
This trial tests a new combination of treatments given before surgery for hormone receptor positive, HER2 negative breast cancer. It uses stereotactic body radiation therapy (SBRT), chemotherapy, and an investigational drug called AK112 to shrink tumors and make surgery easier.
Hear when a new Breast Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.